Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
75.00
+3.80 (5.34%)
Oct 13, 2026, 4:07 PM CET

STO:IBT.B Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,0106807221,212561750
Market Cap Growth
19.81%-5.78%-40.44%116.00%-25.15%-40.36%
Enterprise Value
902515496845193360
Last Close Price
71.2050.5053.6090.0050.0066.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--180517.0315745.8246775.77-
PB Ratio
18.096.464.243.971.691.90
P/TBV Ratio
18.096.464.243.971.691.90

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--123968.0310976.8916081.52-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-2.05-1.37-1.31-1.08-1.01-0.98
Net Debt / FCF Ratio
1.701.991.983.253.916.95
Quick Ratio
1.662.613.297.2718.8529.34
Current Ratio
1.672.723.337.4018.9330.03
Return on Equity (ROE)
-87.44%-47.29%-57.59%-38.65%-18.01%-10.77%
Return on Assets (ROA)
-33.89%-21.49%-30.75%-24.01%-10.85%-6.50%
Return on Capital Employed (ROCE)
-160.30%-65.50%-85.40%-44.10%-19.80%-11.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.54%-9.58%-18.96%-10.15%-11.66%-6.00%
FCF Yield
-6.68%-10.63%-15.67%-8.35%-15.29%-7.42%
Buyback Yield / Dilution
---8.95%-10.14%--